{
  "ticker": "OPL",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02961163",
  "id": "02961163",
  "pages": 37,
  "price_sensitive": false,
  "date": "20250623",
  "time": "1808",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250623/pdf/06l0tnbx7rc66q.pdf",
  "summary": "**Material Information Summary \u2013 OPYL LIMITED (ASX: OPL) General Meeting \u2013 25 July 2025**  \n\n### **Key Agenda Items & Resolutions**  \n\n1. **Ratifications & Capital Raisings**  \n   - **Resolution 1**: Ratification of prior issue of 25,107,195 shares at $0.021/share (12 May 2025) under **Listing Rule 7.1**.  \n   - **Resolution 2**: Ratification of prior issue of 16,892,805 shares at $0.021/share (12 May 2025) under **Listing Rule 7.1A**.  \n   - **Resolution 5**: Ratification of prior issue of 500,000 shares at $0.02/share (18 Dec 2024) to Peak Asset Management.  \n\n2. **New Issuances & Convertible Securities**  \n   - **Resolution 3**: Approval to issue **35,714,286 Placement Options** (1:1 with Placement Shares; $0.03 exercise price, 4-year expiry).  \n   - **Resolution 4**: Approval to issue **8,000,000 Broker Options** (same terms as Placement Options) to Joint Lead Managers.  \n   - **Resolution 7 & 10**: Approval to issue shares + options to Irwin Biotech Nominees (5.56M shares at $0.015 + 5.56M options; 3.86M shares at $0.013 + 2M options).  \n   - **Resolution 8**: Approval to issue 5.93M shares at $0.015 + 5.93M options to Maryton Australia Pty Ltd.  \n\n3. **Related Party Transactions**  \n   - **Resolution 9**: Approval to issue **12.67M shares + 12.67M options** to Director Antanas Guoga at $0.015/share.  \n   - **Resolution 11**: Approval to issue **10M Performance Rights** to Director Saurabh Jain (vesting tied to milestones: $100K sales & CEO recruitment).  \n\n4. **Corporate Action**  \n   - **Resolution 6**: Special resolution to change company name to **Pathkey.AI Limited** (new ASX code: PKY).  \n\n### **Key Dates**  \n- **Meeting Date**: 25 July 2025 (10:30 AM AEST).  \n- **Record Date**: 23 July 2025 (10:30 AM AEST).  \n\n### **Material Impact**  \n- **Dilution**: Potential issuance of **~99M new shares + 85M options/rights** (undiluted base: 235M shares).  \n- **Strategic Shift**: Name change (Resolution 6) signals focus on AI-driven drug discovery.  \n- **Loans Conversion**: Resolutions 7-10 convert $305K in loans (incl. accrued interest) to equity at discounts to market.  \n\n**Voting Exclusions**: Votes from related parties (e.g., Guoga, Jain, Irwin, Maryton) excluded for relevant resolutions.  \n\n**Next Steps**: Shareholders to vote by proxy by 23 July 2025.  \n\n---  \n*Summary tailored for trading/capital markets decisions. Excludes procedural details and non-material disclosures.*",
  "usage": {
    "prompt_tokens": 28006,
    "completion_tokens": 685,
    "total_tokens": 28691,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-23T08:52:07.281441"
}